Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38, 956 patients in a clinical practice setting. Issue 5 (October 2015)

• Record Type: Journal Article
• Authors: Sabale, Ugne; Bodegård, Johan; Sundström, Johan; Östgren, Carl Johan; Nilsson, Peter; Johansson, Gunnar; Svennblad, Bodil; Henriksson, Martin
• Is Part Of: Primary care diabetes. Volume 9:Issue 5(2015)
• Page Start: 330
• Page End: 337
• Publication Date: 2015-10
• Subjects: Type 2 diabetes mellitus -- Healthcare utilization, Healthcare costs, Retrospective observational study; Diabetes -- Periodicals; 616.462
• DOI: 10.1016/j.pcd.2015.01.001
• Languages: English
• ISSNs: 1751-9918

Abstract

Highlights: Data from a retrospective study involving 38, 956 type 2 diabetes (T2D) patients. Newly diagnosed T2D patients from 84 primary care centres in Sweden. Resource use patterns and healthcare cost are presented over 9 year time period. Newly diagnosed diabetes patients need a substantial amount of healthcare services. Hospitalizations are the main cost drivers of healthcare costs. Abstract: Aims: To describe healthcare resource use patterns and estimate healthcare costs of newly diagnosed Type 2 diabetes mellitus (T2DM) patients in Sweden. Methods: Patients with a newly diagnosed T2DM between 1999 and 2009 were identified from 84 Swedish primary care centres. Healthcare resource use data, excluding pharmaceuticals, were extracted from electronic patient records and a national patient register, and reported as per patient mean number of primary care contacts, laboratory tests and hospitalizations. Per patient mean healthcare costs are reported as annual and cumulative costs. Results: During a median (maximum) of 4.6 (9.0) years follow-up; 38, 956 patients (183, 513 patient years) on average made 81 primary care contacts, was hospitalized 2.14 times, and took 31 laboratory tests. Mean per patient annual healthcare costs were €4128 (95% CI, 4054–4199) the first year after diagnosis, €2708 (95% CI, 2641–2776) the second year, and €3030 (95% CI, 2854–3204) in year 9 (2012 values). Mean per patient cumulative healthcare costs were €26, 503 (95% CI, 26, 025–26, 970) at 9 years of follow-up. Hospitalizations accounted for the majority of healthcare costs. Conclusions: Although newly diagnosed T2DM patients require a substantial amount of healthcare services in primary care, hospitalizations account for the majority of healthcare costs.